[1]
2026. Bicalutamide-Mediated Inhibition of Androgen Receptor Signaling and Its Effect on the Invasion and Migration of Ovarian Cancer Cells. New Journal of Biology and Medicine. 2, 2 (Jun. 2026), 21–29. DOI:https://doi.org/10.64354/968ny790.